Press Releases SAMS Statement on the Establishment of the Select Committee on the Strategic Competition Between the U.S. and the CCP Press Releases SAMS Statement on Passage of The Consolidated Appropriations Act of 2023 Resources Op-Ed: To protect the medical supply chain, ‘made in America’ will be key Press Releases SAMS Statement on Shortages of Critical Medicines in the United States Resources New Study Finds U.S. Manufacturers Operating at Half Capacity Press Releases SAMS Comments on Shortages of Flu-fighting Pharmaceuticals Press Releases SAMS Applauds the Appointment of Livia Shmavonian as the Director of the White House ‘Made in America’ Office Press Releases SAMS Response to the Biden Administration’s $2 Billion Investment in Biomanufacturing Statements SAMS Response to National Biotechnology and Biomanufacturing Initiative Resources Member Spotlight: fluidIQ Press Releases Senator Patty Murray Receives Inaugural SAMS Domestic Supply Chain Congressional Champion Award Resources A New Approach to Lyme Disease Statements SAMS Statement on the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Support of Domestic Medical Manufacturing Resources Member Spotlight: iRemedy Resources SAMS + AMMA FY23 CMS IPPS Letter Member's Corner Matt Mackowiak: Let’s Declare Our Independence from Foreign Drug Supply Chains Statements Statement on BARDA’s Five-Year Plan Resources Prioritizing American Manufacturing Resources How to fix our medical supply chain problems Member's Corner A Brief Response to Bill Gates’s NYT Op-Ed